Status:

UNKNOWN

Stellate Block Versus Nimodipine Infusion for Traumatic Brain Injury

Lead Sponsor:

Sohag University

Conditions:

Traumatic Brain Injury

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

the study is designed to perform an intervention for enhancement of cerebral blood flow in patients with traumatic brain injury showing vasospasm through transcranial doppler

Eligibility Criteria

Inclusion

  • patients more than 18 ys old with isolated head trauma and traumatic brain injury

Exclusion

  • • Hemodynamic instability (mean ABP less than 70 mmHg)
  • History of severe systemic disease including cardiopulmonary failure or hepatorenal failure
  • Allergy to local anesthetics
  • Coagulation disorders
  • Abnormal neck structures disturbing normal anatomy as neck tumors

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05182619

Start Date

January 1 2022

End Date

April 1 2023

Last Update

January 10 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.